GeneT researchers present their work at ESGCT 2024
GeneT researchers presented their scientific work at the European Society of Gene and Cell Therapy Congress, which took place from 22 to 25 October 2024 at the La Nuvola Congress Centre in Rome.
In a vibrant atmosphere of scientific sharing and discussion, GeneT displayed eight scientific posters on the various areas of knowledge explored by the Gene and Cell Therapy research group at CIBB—Centre for Innovation in Biomedicine and Biotechnology.
Find out about the themes of the posters and their presenters:
Poster Title | Presenter | Category |
P0154: Hacking Biology: Optimizing AAV-Based Gene Delivery for Enhanced Region-Specific Brain Targeting | Guilherme Gabriel | AAV & non integrative vectors |
P0279: Mesenchymal Stromal Cell potential to restore autophagy and mitochondria health in Machado-Joseph disease | Maria Barros | CNS & sensory diseases |
P0330: Intra-cisterna magna administration of allele-specific AAV-based therapy alleviates neuropathology and motor deficits in Spinocerebellar Ataxia Type 3 | Rui Nobre | CNS & sensory diseases |
P0367: Characterization and therapeutic potency evaluation of SCA3/MJD iPSC-derived neuroepithelial stem cells silenced for mutant ATXN3 | Liliana Mendonça | Disease models, IPS cells & organoids |
P0920: Maximizing Yield and Functionality in saRNA Production: A Comparative Study of Commercial Kits and In Vitro Transcription Conditions | Bruno Marques | Non viral vectors/Nanotechnology/RNA therapeutics |
P0924: Optimizing in vitro transcription methods for enhanced mRNA-based therapeutics | Sara Lopes | Non viral vectors/Nanotechnology/RNA therapeutics |
P0926: Comparative Analysis of Transfection Kits for Linear, Self-Amplifying, and Circular RNA | Cristiana Paulo | Non viral vectors/Nanotechnology/RNA therapeutics |
P0929: A comparative analysis of commercial kits for enhanced circular mRNA production: yield, profile, and in vitro assessment | Dina Pereira | Non viral vectors/Nanotechnology/RNA therapeutics |